tirzepatide 9 mg (Zepbound, Mounjaro): Weight Loss, Diabetes, Dosage & Side Effects certified practitioners Tirzepatide Dosage Chart & Dosing

6 Adverse Reactions The following serious adverse reactions are described below or elsewhere in the prescribing information: Risk of Thyroid C-cell Tumors [see Warnings and Precautions (5.1)] Pancreatitis [see Warnings and Precautions (5.2)] Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin [see Warnings and Precautions (5.3)] Hypersensitivity [see Warnings and Precautions (5.4)] Acute Kidney Injury [see Warnings and Precautions (5.5)] Severe Gastrointestinal Disease [see Warnings and Precautions (5.6)] Diabetic Retinopathy Complications [see Warnings and Precautions (5.7)] Acute Gallbladder Disease [see Warnings and Precautions (5.8)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice

Glucagon-like peptide 1 (GLP-1)

A slower, more deliberate one that lets the body adapt to GLP-1 receptor activation at a pace it can actually handle

Factors like starting BMI, metabolic health, activity level, and dietary choices all influence the rate

Shelf life: 24 months from the manufacturing date

The guidelines are specific and non-negotiable